These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6065348)

  • 1. [Contibution to the significance of 3,4-dimethoxyphenylethylamine in schizophrenias].
    Hanzlícek L
    Cesk Psychiatr; 1967 Oct; 63(5):293-6. PubMed ID: 6065348
    [No Abstract]   [Full Text] [Related]  

  • 2. [Significance and identification of 3,4-dimethoxyphenylethylamine in the urine of schizophrenic patients (pink spot reaction)].
    Stanciu E; Csiky K; Rácz E
    Neurol Psihiatr Neurochir; 1971; 16(4):305-12. PubMed ID: 5118389
    [No Abstract]   [Full Text] [Related]  

  • 3. [Excretion of 3,4-dimethoxyphenylethylamine. Central and peripheral synthesis].
    Dávila R; Zumárraga M; Zamalloa MI; Friedhoff AJ
    Arch Neurobiol (Madr); 1984; 47(1):19-28. PubMed ID: 6721632
    [No Abstract]   [Full Text] [Related]  

  • 4. 3,4-dimethoxyphenethylamine (DMPEA) and schizophrenia.
    Narasimhachari N
    Biol Psychiatry; 1979 Feb; 14(1):215-9. PubMed ID: 420902
    [No Abstract]   [Full Text] [Related]  

  • 5. DMPEA in schizophrenia.
    Schweitzert JW; Friedhoff AJ
    Biol Psychiatry; 1982 Mar; 17(3):400-1. PubMed ID: 7082706
    [No Abstract]   [Full Text] [Related]  

  • 6. [Biochemical diagnosis of schizophrenia].
    Domagk GF
    Hippokrates; 1975 Feb; 46(1):123-4. PubMed ID: 1120711
    [No Abstract]   [Full Text] [Related]  

  • 7. [Current status of studies on dimethoxyphenylethylamine in schizophrenia].
    Friedhoff AJ
    Vestn Akad Med Nauk SSSR; 1969; 24(4):37-41. PubMed ID: 5346213
    [No Abstract]   [Full Text] [Related]  

  • 8. [Biological schizophrenia research].
    Munkvad I
    Ugeskr Laeger; 1977 Nov; 139(45):2687-8. PubMed ID: 595154
    [No Abstract]   [Full Text] [Related]  

  • 9. Excretion of 3,4-dimethoxyphenethylamine (DMPEA) by acute schizophrenics and controls.
    Friedhoff AJ; Park S; Schweitzer JW; Burdock EI; Armour M
    Biol Psychiatry; 1977 Oct; 12(5):643-54. PubMed ID: 588645
    [No Abstract]   [Full Text] [Related]  

  • 10. 3,4-dimethoxyphenylethylamine in schizophrenia.
    Williams CH; Gibson JG; McCormick WO
    Nature; 1966 Sep; 211(5054):1195. PubMed ID: 6008085
    [No Abstract]   [Full Text] [Related]  

  • 11. Investigations on urinary excretion of 3,4 dimethoxyphenylethylamine (the pink spot), the Mauve factor and aromatic compounds in patients with schizophrenia.
    Rao BS; Narayanan HS; Reddy GN
    Indian J Med Res; 1971 Mar; 59(3):455-60. PubMed ID: 5090025
    [No Abstract]   [Full Text] [Related]  

  • 12. Does 3,4-dimethoxyphenylethylamine occur in the urine from schizophrenics and normal persons?
    Pind K; Faurbye A
    Acta Psychiatr Scand; 1966; 42(3):246-51. PubMed ID: 5959088
    [No Abstract]   [Full Text] [Related]  

  • 13. Quantitative investigation on the urinary excretion and metabolism of 3,4-dimethoxyphenylethylamine in schizophrenics and normal individuals.
    Hempel K; Ullrich H; Philippu G
    Biol Psychiatry; 1982 Jan; 17(1):49-59. PubMed ID: 7059639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time study of the urinary excretion of 3,4-dimethoxyphenylethylamine and 3,4-dimethoxyphenylacetic acid by schizophrenic and normal individuals.
    Vogel WH; Ahlberg CD; Horwitt MK
    Int J Neuropsychiatry; 1967 Jun; 3(3):292-7. PubMed ID: 6034737
    [No Abstract]   [Full Text] [Related]  

  • 15. A new concept and further support for the importance and occurrence of 3,4-dimethoxyphenylethylamine (DMPEA) in urine of schizophrenic patients.
    Kalbhen DA; Braun G
    Pharmacology; 1973; 9(1):52-6. PubMed ID: 4708978
    [No Abstract]   [Full Text] [Related]  

  • 16. The "pink spot," 3,4-dimethoxyphenylethylamine, common tea, and schizophrenia.
    Stabenau JR; Creveling CR; Daly J
    Am J Psychiatry; 1970 Nov; 127(5):611-6. PubMed ID: 5491537
    [No Abstract]   [Full Text] [Related]  

  • 17. The "pink spot", 3,4-dimethoxyphenylethylamine and dopamine. Relationship to Parkinson's disease and to schizophrenia.
    Barbeau A
    Rev Can Biol; 1967 Mar; 26(1):55-79. PubMed ID: 4865100
    [No Abstract]   [Full Text] [Related]  

  • 18. [Determination and occurrence of 3,4-dimethoxyphenylethylamine (DMPEA) in the urine of acute schizophrenics (author's transl)].
    Braun G; Kalbhen DA; Müller J; Vahar-Matiar H
    Arch Psychiatr Nervenkr (1970); 1974 Mar; 218(3):195-210. PubMed ID: 4838948
    [No Abstract]   [Full Text] [Related]  

  • 19. Failure to detect 3,4-dimethoxyphenylethylamine in the urine of psychotic children.
    Faurbye A; Pind K
    Acta Psychiatr Scand Suppl; 1966; 191():136-48. PubMed ID: 4164427
    [No Abstract]   [Full Text] [Related]  

  • 20. 3,4-Dimethoxyphenylethylamine excretion of normals and schizophrenics, behaviour during total fasting.
    Knoll E; Wisser H; Emrich HM
    Clin Chim Acta; 1978 Nov; 89(3):493-502. PubMed ID: 709888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.